Literature DB >> 18881103

Keratoconjunctivitis sicca and chronic polyarthritis.

H SJOGREN.   

Abstract

Entities:  

Keywords:  ARTHRITIS

Mesh：

Year:  1948        PMID： 18881103

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  6 in total

1.  [Steroid excretion in Sjögren syndrome].

Authors:  J G RAUSCH-STROOMAN; H DORKEN
Journal:  Klin Wochenschr       Date:  1956-03-01

2.  [Eye manifestations of generalized scleroderma. (Aspects in common with Sjogren's Syndrome)].

Authors:  C A Stucchi; J D Geiser
Journal:  Doc Ophthalmol       Date:  1967       Impact factor: 2.379

3.  Development of malignant lymphoma in myoepithelial sialadenitis (Sjögren's syndrome).

Authors:  U Schmid; D Helbron; K Lennert
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

4.  Histopathological changes in tear-secreting tissues and cornea in a mouse model of autoimmune disease.

Authors:  Masaya Hiraishi; Md Abdul Masum; Takashi Namba; Yuki Otani; Yaser Ha Elewa; Osamu Ichii; Yasuhiro Kon
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-21

5.  Inter-grader Agreement of the Ocular Staining Score in the Sjögren's International Clinical Collaborative Alliance (SICCA) Registry.

Authors:  Jennifer Rose-Nussbaumer; Thomas M Lietman; Caroline H Shiboski; Stephen C Shiboski; Vatinee Y Bunya; Esen K Akpek; Muthiah Srinivasan; Jeena Mascarenhas; Giacomina Massaro-Giordano; Nancy A McNamara; John P Whitcher; Bruce D Gaynor
Journal:  Am J Ophthalmol       Date:  2015-08-22       Impact factor: 5.258

Review 6.  A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details.

Authors:  Hisanori Umehara; Kazuichi Okazaki; Yasufumi Masaki; Mitsuhiro Kawano; Motohisa Yamamoto; Takako Saeki; Shoko Matsui; Takayuki Sumida; Tsuneyo Mimori; Yoshiya Tanaka; Kazuo Tsubota; Tadashi Yoshino; Shigeyuki Kawa; Ritsuro Suzuki; Tsutomu Takegami; Naohisa Tomosugi; Nozomu Kurose; Yasuhito Ishigaki; Atsushi Azumi; Masaru Kojima; Shigeo Nakamura; Dai Inoue
Journal:  Mod Rheumatol       Date:  2011-09-01       Impact factor: 3.023
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.